Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[Clinical features and prognosis of children with acute lymphoblastic leukemia and different platelet levels].

Zhang AL, Chen XJ, Zou Y, Yang WY, Guo Y, Wang SC, Zhang L, Liu XM, Ruan M, Liu TF, Qi BQ, Zhu XF.

Zhongguo Dang Dai Er Ke Za Zhi. 2019 Aug;21(8):766-771. Chinese.

PMID:
31416500
2.

[Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].

Liu X, Zou Y, Wang H, Chen X, Ruan M, Chen Y, Yang W, Guo Y, Liu T, Zhang L, Wang S, Zhang J, Liu F, Cai X, Qi B, Chang L, Zhu X.

Zhonghua Er Ke Za Zhi. 2014 Jun;52(6):449-54. Chinese.

PMID:
25190166
3.

The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.

Güneş AM, Oren H, Baytan B, Bengoa SY, Evim MS, Gözmen S, Tüfekçi O, Karapınar TH, Irken G.

Ann Hematol. 2014 Oct;93(10):1677-84. doi: 10.1007/s00277-014-2106-0. Epub 2014 May 27.

PMID:
24863691
4.

[Clinical effect of CCLG-ALL2008 regimen in treatment of children and adolescents aged >10 years with acute lymphoblastic leukemia].

Lan Y, Chen XJ, Zou Y, Ruan M, Zhu XF.

Zhongguo Dang Dai Er Ke Za Zhi. 2019 May;21(5):405-410. Chinese.

PMID:
31104652
5.

[Clinical analysis on adult acute T-lymphoblastic leukemia].

Zhang Q, Zhou CL, Fu MW, Wang JY, Lin D, Liu BC, Li W, Mi YC, Wang JX.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Apr;20(2):478-82. Chinese.

PMID:
22541122
6.

[Clinical features of children with relapsed acute lymphoblastic leukemia treated with the CCLG-ALL2008 protocol].

Chen XJ, Zou Y, Yang WY, Guo Y, Wang SC, Zhang L, Liu XM, Ruan M, Liu TF, Qi BQ, Zhu XF.

Zhongguo Dang Dai Er Ke Za Zhi. 2015 Apr;17(4):321-6. Chinese.

7.

[Prognostic Value of Prednisone Response in CCLG-ALL 2008].

Ren YY, Zou Y, Chang LX, An WB, Wan Y, Zhang JL, Liu TF, Zhu XF.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Jun;23(3):642-6. doi: 10.7534/j.issn.1009-2137.2015.03.008. Chinese.

PMID:
26117009
8.

[Effect of increasing the intensity of chemotherapy on the prognosis of acute lymphoblastic leukemia in children with IKZF1 deletion].

Zheng YZ, Li J, LE SH, Zheng H, Hua XL, Chen ZS, Hu JD.

Zhongguo Dang Dai Er Ke Za Zhi. 2019 Jul;21(7):690-695. Chinese.

PMID:
31315770
9.

[Long-term clinical effect of the CCLG-ALL2008 regimen in treatment of childhood acute lymphoblastic leukemia with different molecular biological features].

Chen XJ, Zou Y, Liu XM, Yang WY, Guo Y, Ruan M, Liu F, Chen YM, Zhang L, Wang SC, Zhu XF.

Zhongguo Dang Dai Er Ke Za Zhi. 2019 Sep;21(9):890-893. Chinese.

PMID:
31506148
10.

[Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].

Zhang YL, Zhao WL, Nie SS, Guo DD, Ji ZH, Chai YH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1496-500. Chinese.

PMID:
22169311
11.

[Clinical Significance of Minimal Residual Disease in Risk Stratification and Prognosis of Childhood B-lineage Acute Lymphoblastic Leukemia].

An FY, Zhang SH, Kong LJ, Liang Y, Xu JX, He HL, Chai YH, Zhao WL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Jun;25(3):729-735. doi: 10.7534/j.issn.1009-2137.2017.03.017. Chinese.

PMID:
28641626
12.

Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.

Tomizawa D, Kato M, Takahashi H, Fujimura J, Inukai T, Fukushima T, Kiyokawa N, Koh K, Manabe A, Ohara A.

Int J Hematol. 2015 Nov;102(5):602-10. doi: 10.1007/s12185-015-1869-y. Epub 2015 Sep 26.

PMID:
26410102
13.

Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age.

Behm FG, Raimondi SC, Frestedt JL, Liu Q, Crist WM, Downing JR, Rivera GK, Kersey JH, Pui CH.

Blood. 1996 Apr 1;87(7):2870-7.

14.

Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.

Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K, Ishii E.

Blood. 2004 Dec 1;104(12):3527-34. Epub 2004 Aug 5.

15.

[Clinical significance and frequency of the 11q23/MLL genetic molecular alteration in Chilean infants with acute leukemia].

Cabrera ME, Campbell M, Quintana J, Undurraga MS, Ford AA, Greaves MF.

Rev Med Chil. 2001 Jun;129(6):634-42. Spanish.

PMID:
11510203
16.

[Autologous hematopoietic stem cell transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: a single center experience from the BDHALL2000/02 protocol].

Wang T, Zou D, Zhang Y, Li Z, Sui W, Fu M, Zhao Y, Wang J, Mi Y, Feng S, Han M, Qiu L.

Zhonghua Xue Ye Xue Za Zhi. 2015 Jun;36(6):480-4. doi: 10.3760/cma.j.issn.0253-2727.2015.06.007. Chinese.

PMID:
26134012
17.

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF; PETHEMA Group, Spanish Society of Hematology.

Haematologica. 2002 Feb;87(2):154-66.

18.

Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).

Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantù-Rajnoldi A, Aricò M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G.

Haematologica. 1998 Nov;83(11):967-73.

19.

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.

Pui CH, Behm FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC, Head DR, Mahmoud HH, Sandlund JT, Furman WL, et al.

J Clin Oncol. 1994 May;12(5):909-15.

PMID:
8164041
20.

[Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].

Lu XT.

Beijing Da Xue Xue Bao Yi Xue Ban. 2013 Apr 18;45(2):327-32. Review. Chinese.

Supplemental Content

Support Center